You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chimeric Targeting Molecule (CTM)

Showing 1 - 25 of 4,981
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

Not yet recruiting
  • Cancer
  • +3 more
  • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
  • Singapore, Singapore
    National University Hospital
Mar 20, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
  • +2 more
Aug 11, 2022

Colorectal Cancer, Triple Negative Breast Cancer, Sarcoma Trial in Johor Bahru (Adoptive Cell Transfer of NKG2DL-targetting

Unknown status
  • Colorectal Cancer
  • +5 more
  • Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell
  • Johor Bahru, Johor, Malaysia
    Landmark Medical Centre
Sep 26, 2019

Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

Recruiting
  • Non-hodgkin Lymphoma,B Cell
  • Autologous CD19-STAR-T cell
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +3 more
  • Universal CD7-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 17, 2023

Metastatic Breast Cancer Trial in Duarte (huMNC2-CAR44 CAR T cells, huMNC2-CAR44 CAR T cells @ RP2D)

Recruiting
  • Metastatic Breast Cancer
  • huMNC2-CAR44 CAR T cells
  • huMNC2-CAR44 CAR T cells @ RP2D
  • Duarte, California
    City of Hope Medical Center
Dec 22, 2021

CAR, Acute Myeloid Leukemia Trial in Hefei (TAA05 cell injection)

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • TAA05 cell injection
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Nov 3, 2021

Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023

SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

Not yet recruiting
  • SLE (Systemic Lupus)
  • CAR T-cell therapy
  • Bangkok, Please Select, Thailand
    King Chulalongkorn Memorial Hospital
Nov 23, 2023

Aging, Mobility Limitation, Sedentary Behaviour Trial in Vancouver (Choose to Move)

Active, not recruiting
  • Aging
  • +5 more
  • Choose to Move
  • Vancouver, British Columbia, Canada
    Centre for Hip Health and Mobility, Robert H.N. Ho Research Cent
Jan 6, 2023

Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

Recruiting
  • Gastric Cancer
  • Chimeric antigen receptor T cell preparation targeting Claudin18.2
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jul 11, 2023

Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))

Recruiting
  • Advanced Solid Tumors
  • Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023

Key Genes in Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Carcinoma
  • None of intervention
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023

T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

Recruiting
  • T-cell Lymphoma
  • T-cell Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Dec 16, 2022

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Aging, Mobility Limitation, Sedentary Behavior Trial in Vancouver (Choose to Move - Next Steps)

Enrolling by invitation
  • Aging
  • +4 more
  • Choose to Move - Next Steps
  • Vancouver, British Columbia, Canada
    Centre for Hip Health and Mobility, Robert H.N. Ho Research Cent
Aug 18, 2022

Aging, Physical Inactivity, Mobility Limitation Trial in Vancouver (Choose to Move)

Completed
  • Aging
  • +4 more
  • Choose to Move
  • Vancouver, British Columbia, Canada
    Centre for Hip Health and Mobility
Aug 9, 2022

Respiratory Syncytial Virus Prevention Trial in United States (Ad26.RSV.preF-based vaccine)

Completed
  • Respiratory Syncytial Virus Prevention
  • Ad26.RSV.preF-based vaccine
  • San Diego, California
  • +8 more
Oct 25, 2022

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

Not yet recruiting
  • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 28, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Neuroblastoma Trial (GD2 CAR T cells)

Not yet recruiting
  • Neuroblastoma
  • GD2 CAR T cells
  • (no location specified)
Aug 5, 2023

Cricothyroidotomy Trial in London (Palpation, Ultrasound)

Completed
  • Cricothyroidotomy
  • Palpation
  • Ultrasound
  • London, United Kingdom
    Great Ormond Street Hospital for Sick Children NHS Foundation Tr
Oct 3, 2022

Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

Recruiting
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • CD22CART cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022